Lavipharm S.A. (ATH:LAVI)

Lavipharm Revenue

Lavipharm had revenue of 14.65M EUR in the quarter ending March 31, 2026, with 15.35% growth. This brings the company's revenue in the last twelve months to 64.53M, up 22.98% year-over-year. In the year 2025, Lavipharm had annual revenue of 62.58M with 18.20% growth.

• Revenue (ttm): 64.53M
• Revenue Growth: +22.98%
• P/S Ratio: 4.09
• Revenue / Employee: 226.44K
• Employees: 285
• Market Cap: 264.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.58M	9.64M	18.20%
Dec 31, 2024	52.95M	5.11M	10.68%
Dec 31, 2023	47.84M	8.78M	22.48%
Dec 31, 2022	39.06M	-667.00K	-1.68%
Dec 31, 2021	39.72M	2.09M	5.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error